Dr. Abdulelah Alhawsawi, MD - CEO, Novo Genomics, Saudi Arabia - Personalized And Safe Healthcare And Wellness

Progress, Potential, and Possibilities

Send us a text

Dr. Abdulelah Alhawsawi, MD is the CEO of Novo Genomics ( https://novogenomics.sa/ ), a company located in KSA with a vision of being the regionally trusted, globally recognized biotech leader in the field of genomics & multiomics.
Dr. Alhawsawi is the former Founding Director General of the Saudi Patient Safety Center ( SPSC - https://www.spsc.gov.sa/English/Pages/Home.aspx ), and MOH Advisor on Patient Safety and was involved in the core efforts establishing SPSC as a WHO Collaborating Center for patient safety policies and strategies (1 of only 5 WHOcc worldwide in this field).
Dr. Alhawsawi is a consultant to several national and international quality and safety organizations and recently became a board member and Vice President of the Global Sepsis Alliance ( GSA - https://globalsepsisalliance.org/ ) as well as a Board member of Joint Commission Resources Board. He was part of the Expert Panel on the 3rd Global Patient Safety Challenge of the WHO and chaired the Organizing Committee for the 4th Global Ministerial Summit on Patient Safety in Jeddah, Saudi Arabia.
Dr. Alhawsawi has helped introduce Patient Safety as a G20 priority in the 2020 G20 of Saudi Arabia. Currently, Dr. Alhawsawi is part of the WHO’s Global Patient Safety Action Plan Taskforce and is a Global Ambassador of the G20 Health & Development Partnership ( https://g20healthpartnership.com/dr-abdulelah-alhawsawi/ ).
Dr. Alhawsawi holds a bachelor’s degree in Medicine from King Abdulaziz University, Jeddah, Saudi Arabia, is Dual board certified in transplant and hepato-biliary surgery (American – Canadian), and he completed his training in Mount Sinai School of Medicine, New York. He is a member of numerous medical societies and national quality committees.
#AbdulelahAlhawsawi #PatientSafety #SaudiArabia #PreventableHarm #Sepsis #AntimicrobialResistance #HealthDiplomacy #ScienceDiplomacy #NovoGenomics #Genomics #Multiomics #PersonalizeMedicine #Agrigenomics #Premarital #Prenatal #NewbornCare#HereditaryDiseases #Oncology#GeneticsCounseling
#ClinicalGenetics

Support the Show.